In summary, the results reported in this study help clarify why α-TEA is such a potent apoptotic agent in human breast cancer cell lines, and suggest potential utility for α-TEA in combination therapy with ERK and mTOR inhibitors. The gene discussed is MTOR; the disease is breast cancer.